|
Report No. : |
347710 |
|
Report Date : |
06.11.2015 |
IDENTIFICATION DETAILS
|
Name : |
PHARMACARE EGYPT FOR TRADING AGENCY |
|
|
|
|
Registered Office : |
989 Corniche El Nile Street, El Malek Al Saleh, El Manial, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Date of Incorporation : |
27.03.2000 |
|
|
|
|
Com. Reg. No.: |
43545 |
|
|
|
|
Legal Form : |
Sole Proprietorship |
|
|
|
|
Line of Business : |
Engaged in the manufacture of pharmaceuticals, cosmetics and beauty
products. |
|
|
|
|
No. of Employees : |
120 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Egypt |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name :
PHARMACARE EGYPT FOR TRADING AGENCY
Country of Origin :
Egypt
Legal Form :
Sole Proprietorship
Registration Date :
27th March 2000
Commercial Registration Number :
43545, Cairo
Tax Card Number :
210-237-945
Invested Capital :
£E 5,000,000
Total Workforce : 120
Activities :
Manufacturers of pharmaceuticals, cosmetics and beauty products.
Financial Condition :
Fair
Payments :
Nothing detrimental uncovered
Operating Trend :
Steady
Person Interviewed :
Iman Hamdy, Personal Assistant
PHARMACARE EGYPT FOR TRADING AGENCY
Registered &
Physical Address
Street : 989 Corniche
El Nile Street
Area : El Malek Al
Saleh, El Manial
Town : Cairo
Country : Egypt
Telephone : (20-2) 23649485
/ 23680019
Facsimile : (20-2)
25322177
Mobile : (20-12)
9776118
Email : pharmacare@link.net
/ dr.hamdy_pharmacare@yahoo.com
/ info@pharmacareeg.com
Premises
Subject operates from a large suite of offices and a factory that are
rented and located in the Industrial Area of Cairo.
Name Position
Dr Ossama Sayed Antar Proprietor
Dr Hamdy El Gebeley Marketing
Manager
Dr Ashraf Hanafy Commercial
Manager
Iman Hamdy Personal
Assistant
Date of Establishment : 27th
March 2000
Legal Form : Sole
Proprietorship
Commercial Reg. No. : 43545, Cairo
Tax Card No. : 210-237-945
Invested Capital : £E 5,000,000
Dr Ossama Sayed Antar is the sole proprietor of the business.
Ago Exim Pvt Ltd
233 Swastik Plaza
Subhash Nagar
Pokhran Road No. 2
Thane 400606
India
Tel: (91-22) 21731583 / 21717273
Multi Care
989 Corniche El Nile Street
El Malek El Saleh
El Manial
Cairo
Multi Care
Dubai
United Arab Emirates
Pharmacare
Saudi Arabia
Activities: Engaged in the manufacture of pharmaceuticals, cosmetics and beauty
products.
Import Countries: India, Greece, New Zealand and the United States
of America.
International Suppliers:
Belcare India
Proel Greece
Natural Life New
Zealand
RX Vitamins
United States of America
Export Countries: Saudi Arabia
Operating Trend: Steady
Subject has a workforce of 120 employees.
Financial highlights provided by local sources are given below:
Currency: Egyptian Pound (£E)
Year Ending 31/12/13: Year Ending 31/12/14:
Total Sales £E
65,630,000 £E
66,800,000
Local sources consider subject’s financial condition to be Fair.
The above financial figures are based on estimations by our local
sources.
Commercial International Bank (CIB)
Nile Tower Building
21-23 Giza Street
PO Box: 2430
Cairo
Tel: (20-2) 25703043
Fax: (20-2) 25703172 / 25072691
No complaints regarding subject’s payments have been reported.
During the course of this investigation nothing detrimental was
uncovered regarding subject’s operating history or the manner in which payments
are fulfilled. As such the business is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.65.67 |
|
|
1 |
Rs.101.02 |
|
Euro |
1 |
Rs.71.35 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.